Cite
HARVARD Citation
Endo, Y. et al. (2021). Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis. Modern rheumatology. 31 (5), pp. 972-978. [Online].